Skip to main content
Comvita Limited logo

Comvita Limited — Investor Relations & Filings

Ticker · CVT ISIN · NZCVTE0001S7 LEI · 984500F1545B0F2DAA24 NZX Manufacturing
Filings indexed 495 across all filing types
Latest filing 2018-12-17 Regulatory Filings
Country NZ New Zealand
Listing NZX CVT

About Comvita Limited

http://www.comvita.co.nz/

Comvita Limited specializes in the production and global distribution of premium Manuka honey and bee-derived health products. The company manages a vertically integrated supply chain, overseeing operations from apiary management to final product formulation. Its core portfolio includes UMF-certified Manuka honey, propolis, royal jelly, and olive leaf extract, alongside specialized skincare and oral care solutions. Comvita emphasizes scientific research and rigorous quality standards to validate the therapeutic properties of its offerings. The company serves a diverse international market, positioning itself as a leader in sustainable beekeeping practices and natural health science. Its operations prioritize environmental stewardship and the preservation of bee populations to ensure the long-term viability of its raw material sources.

Recent filings

Filing Released Lang Actions
Explanation of S&P Dow Jones Index Changes
Regulatory Filings Classification · 95% confidence The document is a short announcement dated 18 December 2018 explaining the removal of Comvita from the S&P Dow Jones NZX50 and NZX Mid Cap Indices due to declining market capitalization. It discusses the impact on share price and mentions a future announcement of the Interim Financial Result for the six months ended 31 December 2018, to be released on 26 February 2019. The document does not contain any financial statements or substantive financial data itself, nor does it present a full report. It is primarily an update or regulatory announcement about index changes and share price impact, with a forward-looking statement about a future report. The document length is only 1862 characters, which is short and consistent with an announcement rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2018-12-17 English
S&P Dow Jones Indices Announcement
Regulatory Filings Classification · 95% confidence The document is an announcement from S&P Dow Jones Indices regarding the December 2018 quarterly rebalance of the S&P/NZX indices. It lists additions and removals of companies in various indices effective on a specific date. The content is about index composition changes, not a financial report, earnings release, or management discussion. It is a regulatory announcement about index changes, which does not fit into categories like Annual Report, Earnings Release, or Capital Update. It is not a report publication or certification. The best fitting category is Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2018-12-17 English
Ongoing Disclosure Notices – Multiple
Director's Dealing Classification · 100% confidence The document contains multiple disclosures of directors and senior managers acquiring shares in the company, including details such as the number of shares before and after acquisition, transaction dates, and purchase prices. It references sections of the Financial Markets Conduct Act 2013, indicating regulatory compliance disclosures. The document is primarily about personal share transactions by company directors and executives, which fits the definition of Director's Dealing filings. The document length is 7585 characters, which is sufficient to contain detailed transaction information rather than just an announcement. There is no indication that this is a full financial report, earnings release, or other types of filings. Therefore, the document is best classified as a Director's Dealing report.
2018-12-12 English
144,375 redeemable shares converted to ordinary shares
Share Issue/Capital Change Classification · 95% confidence The document is a notification to the NZX (New Zealand Stock Exchange) about the conversion of redeemable shares into ordinary shares and the issuance of securities to company executives under a share scheme. It includes details such as the class of security, number issued, issue price, and authority for the issue. The content is focused on share issuance and capital changes rather than financial results, management changes, or regulatory filings. The document length is short (2411 characters) and it is a formal announcement of a share issue event. Therefore, it fits the category of Share Issue/Capital Change (SHA).
2018-12-05 English
Ongoing Disclosure Notices – Multiple
Director's Dealing Classification · 100% confidence The document is titled 'Disclosure of Directors and Senior Managers Relevant Interests' and references sections 297(2) and 298(2) of the Financial Markets Conduct Act 2013. It details transactions by directors and senior managers involving acquisition or disposal of shares, including number of shares before and after transactions, nature of interest, and transaction details. It includes certifications by the directors. There is no financial performance data, earnings information, or report publication. The content is focused on insider share transactions by company directors and senior managers. This matches the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives (insider trades). The document length and detail support this classification with high confidence.
2018-11-23 English
Implementation of Manuka Plantation Strategy for Comvita
Regulatory Filings Classification · 90% confidence The document is a company announcement dated 19 November 2018 regarding the implementation of a Manuka Plantation Strategy by Comvita Limited. It discusses a partnership with MyFarm Investments Limited, details about the plantation scale, genetic improvement programs, and environmental considerations. There are no financial statements, regulatory filings, or detailed financial data presented. The document is a strategic business update and partnership announcement rather than a formal financial report or regulatory filing. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Capital/Financing Update. It is also not a presentation or a call transcript. Given the nature of the content as a business strategy and partnership announcement, the best fitting category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous company announcements that do not fit other specific categories.
2018-11-18 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.